Journal article
P2Y12 receptor inhibitor resistance and coronary artery disease
Abstract
PURPOSE OF REVIEW: Platelet P2Y12 receptor inhibitors are routinely prescribed for patients after acute coronary syndromes and percutaneous coronary interventions. Patients may have underresponsiveness (or resistance) to these drugs and in particular to clopidogrel, the most often used type. This review aims to focus on the concept of P2Y12 receptor inhibitor resistance and discuss incidence, mechanisms, novel diagnostic techniques and past and …
Authors
So DYF; Bagai A; Tran U; Verma S; Mehta SR
Journal
Current Opinion in Cardiology, Vol. 32, No. 5, pp. 617–626
Publisher
Wolters Kluwer
Publication Date
9 2017
DOI
10.1097/hco.0000000000000440
ISSN
0268-4705